Prevalence of Epilepsy and Other Associated Diseases among Children: A Cross-Sectional Study
DOI:
https://doi.org/10.63278/10.63278/mme.v31.1Abstract
Objective: This research aims to determine the prevalence of epilepsy and other associated diseases among children.
Methods: The research will employ a cross-sectional study design to assess the prevalence of epilepsy and its association with other diseases. Cross-sectional studies allow for the simultaneous collection of data from a diverse sample of individuals within a specific population, providing a snapshot of disease prevalence and comorbidity patterns at a given point in time.
Results: The study included 550 participants. The most frequent age among them was 1-5 years (n= 206, 37.5%), followed by 6-9 years (n= 147, 26.7%), then 10-14 years (n=142, 25.8%). Figure 1 shows the age distribution among study participants. The most frequent gender among study participants was male (n= 318, 57.8%), followed by female (n= 232, 42.1%). Figure 2 shows the gender distribution among study participants. Participants were asked if the child suffered from epilepsy or seizures. The most frequent answers were yes (n=378, 68.7%) and no (n=172, 31.2%). The most frequent type of epilepsy was generalized epilepsy (n=282, 74.6%), followed by focal epilepsy (n=96, 25.4%). Figure 4 shows the type of epilepsy distribution among study participants.
Conclusion:
This study revealed a high prevalence of epilepsy among children, with generalized epilepsy being the most common subtype. Significant associations were identified between epilepsy and comorbidities such as stress, anxiety, and depression, highlighting the multifaceted impact of this condition on affected individuals and their families. The findings underscore the necessity of comprehensive diagnostic approaches and tailored management strategies to address not only epilepsy but also its associated physical and psychological burdens.
References
World Health Organization. Epilepsy. World Health Organization. [ Aug; 2022 ]. https://www.who.int/news-room/fact-sheets/detail/epilepsy.
Al Rajeh S, Awada A, Bademosi O, Ogunniyi A. The prevalence of epilepsy and other seizure disorders in an Arab population: a community-based study. Seizure. 2001 Sep 1;10(6):410-4.
Lu E, Pyatka N, Burant CJ, Sajatovic M. Systematic literature review of psychiatric comorbidities in adults with epilepsy. Journal of clinical neurology (Seoul, Korea). 2021 Apr;17(2):176.
Asadi-Pooya AA, Kanemoto K, Kwon OY, Taniguchi G, Dong Z, Chinvarun Y, Yu HY, McGonigal A, Kanner AM, Park SP. Depression in people with epilepsy: How much do Asian colleagues acknowledge it?. Seizure. 2018 Apr 1;57:45-9.
Tegegne MT, Mossie TB, Awoke AA, Assaye AM, Gebrie BT, Eshetu DA. Depression and anxiety disorder among epileptic people at amanuel specialized mental hospital, Addis Ababa, Ethiopia. BMC psychiatry. 2015 Dec;15:1-7.
Sylla M, Vogel AC, Bah AK, Tassiou NR, Barry SD, Djibo BA, Toure ML, Foksona S, Konaté M, Cisse FA, Mateen FJ. Prevalence, severity, and associations of depression in people with epilepsy in Guinea: A single-center study. Epilepsy & Behavior. 2020 Dec 1;113:107475.
Madandola NO, Sale S, Adebisi AS, Obembe A, Salihu AS, Bakare AT, Danjuma IA. Sociodemographic and clinical variables of depression among patients with epilepsy in a neuropsychiatric hospital in Nigeria. Depression research and treatment. 2020 Feb 12;2020.
Weatherburn CJ, Heath CA, Mercer SW, Guthrie B. Physical and mental health comorbidities of epilepsy: population-based cross-sectional analysis of 1.5 million people in Scotland. Seizure. 2017 Feb 1;45:125-31.
Hecimovic H, Santos JM, Carter J, Attarian HP, Fessler AJ, Vahle V, Gilliam F. Depression but not seizure factors or quality of life predicts suicidality in epilepsy. Epilepsy & Behavior. 2012 Aug 1;24(4):426-9.
Mubaraki AA, Sibyani AK, Alkhawtani RA, Alqahtani BG, Alaynayn FK. Prevalence of depression among epileptic patients in Taif City, Saudi Arabia. Neurosciences Journal. 2021 Oct 1;26(4):366-71.
Afifi T, Elessi K, Samaan M, Alaqad A, Abu Elhatal H, Abu-Lamzi A. Management of Epilepsy among Children in the Gaza Strip: A Multicenter Clinical Audit. Dubai Medical Journal. 2019 Sep 11;2(3):90-8.
World Health Organization; Jan, 2009. Epilepsy Fact Sheet No 999, 2009. Available at: http://www.who.int/mediacentre/factsheets/fs999/en/index.html. Accessed on April 2, 2024.
Proposal for revised classification of epilepsies and epileptic syndromes. Commission on Classification and Terminology of the International League Against Epilepsy. Epilepsia. 1989;30(4):389–399.
Schachter SC. Seizure disorders. Med Clin North Am. 2009;93(2):343–351.
French JA, Kanner AM, Bautista J, et al. Efficacy and tolerability of the new anti-epileptic drugs II: Treatment of refractory epilepsy. Neurology. 2004;62(8):1261–1273.
Heakal R. What Is An Emerging Market Economy? 2009. Available at: http://www.investopedia.com/articles/03/073003.asp#axzz1Z4eUuEFk. Accessed on April 2, 2024.
Newton CR. Status epilepticus in resource-poor countries. Epilepsia. 2009;50(12):54–55.
International League Against Epilepsy [homepage] Available at: www.ilae-epilepsy.org. Accessed on April 2, 2024.
Somoza MJ, Forlenza RH, Brussino M, Licciardi L. Epidemiological survey of epilepsy in the primary school population in Buenos Aires. Neuroepidemiology. 2005;25(2):62–68.
Melcon MO, Kochen S, Vergara RH. Prevalence and clinical features of epilepsy in Argentina. A community-based study. Neuroepidemiology. 2007;28(1):8–15.
Somoza MJ, Forlenza RH, Brussino M, Centurión E. Epidemiological survey of epilepsy in the special school population in the city of Buenos Aires. A comparison with mainstream schools. Neuroepidemiology. 2009;32(2):129–135.
Al Rajeh S, Awada A, Bademosi O, Ogunniyi A. The prevalence of epilepsy and other seizure disorders in an Arab population: a community-based study. Seizure. 2001;10(6):410–414.
Benamer HT, Grosset DG. A systematic review of the epidemiology of epilepsy in Arab countries. Epilepsia. 2009;50(10):2301–2304.
Kwong KL, Chak WK, Wong SN, So KT. Epidemiology of childhood epilepsy in a cohort of 309 Chinese children. Pediatr Neurol. 2001;24(4):276–282.
Fong GC, Mak W, Cheng TS, Chan KH, Fong JK, Ho SL. A prevalence study of epilepsy in Hong Kong. Hong Kong Med J. 2003;9(4):252–257.
Hui AC, Lam JM, Wong KS, Kay R, Poon WS. Vagus nerve stimulation for refractory epilepsy: long term efficacy and side-effects. Chin Med J (Engl) 2004;117(1):58–61.
Chen CC, Chen TF, Hwang YC, et al. Population-based survey on prevalence of adult patients with epilepsy in Taiwan (Keelung community-based integrated screening no.12) Epilepsy Res. 2006;72(1):67–74.
Velez A, Eslava-Cobos J. Epilepsy in Colombia: epidemiologic profile and classification of epileptic seizures and syndromes. Epilepsia. 2006;47(1):193–201.
Shah PA, Shapoo SF, Koul RK, Khan MA. Prevalence of epilepsy in school-going children (6–18 years) in Kashmir Valley of North-west India. J Indian Med Assoc. 2009;107(4):216–218.
Halász P, Cramer JA, Hodoba D, et al.BIA-2093-301 Study Group Long-term efficacy and safety of eslicarbazepine acetate: results of a 1-year open-label extension study in partial-onset seizures in adults with epilepsy. Epilepsia. 2010;51(10):1963–1969.
Onal AE, Tumerdem Y, Ozturk MK, et al. Epilepsy prevalence in a rural area in Istanbul. Seizure. 2002;11(6):397–401.
Serdaroğlu A, Ozkan S, Aydin K, Gücüyener K, Tezcan S, Aycan S. Prevalence of epilepsy in Turkish children between the ages of 0 and 16 years. J Child Neurol. 2004;19(4):271–274.
Calisir N, Bora I, Irgil E, Boz M. Prevalence of epilepsy in Bursa city center, an urban area of Turkey. Epilepsia. 2006;47(10):1691–1699.
Velioglu SK, Bakirdemir M, Can G, Topbas M. Prevalence of epilepsy in northeast Turkey. Epileptic Disord. 2010;12(1):22–37.
Cowling BJ, Shaw JE, Hutton JL, Marson AG. New statistical method for analyzing time to first seizure: example using data comparing carbamazepine and valproate monotherapy. Epilepsia. 2007;48(6):1173–1178.
Kochen S, Giagante B, Oddo S. Spike-and-wave complexes and seizure exacerbation caused by carbamazepine. Eur J Neurol. 2002;9(1):41–47.
Anand K, Jain S, Paul E, Srivastava A, Sahariah SA, Kapoor SK. Development of a validated clinical case definition of generalized tonic-clonic seizures for use by community-based health care providers. Epilepsia. 2005;46(5):743–750.
Downloads
How to Cite
Issue
Section
License
Copyright (c) 2024 Najya Abdullah Attia, Ahmed Shutaywi Alharbi, Hoda Jehad Abousada, Meshal Fahad Alhajji, Wejdan Faea Asiri, Mohammed Faez Al Qaed, Ayan Adel Alghamdi, Saadiah Mohammed Alhassani, Nura Mohammed Bahkali, Asail Abdulfatah Alharbi, Nada Nasser Aljohani, Tasneem Hassan Alkayali, Ahdab Abdulaziz mufti, Abdulaziz Ali Alghamdi, Hind Mauafaq Aljifri
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their published articles online (e.g., in institutional repositories or on their website, social networks like ResearchGate or Academia), as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
Except where otherwise noted, the content on this site is licensed under a Creative Commons Attribution 4.0 International License.
According to the 